2015 American Transplant Congress
Suboptimal Vaccination Coverage After Liver Transplantation: Opportunity for Improvement
Cincinnati Children's Hospital Medical Center, Cincinnati, OH.
Elimination of vaccine-preventable disease after solid organ transplantation (SOT) has the potential to improve outcomes. We evaluated immunization rates and the impact of directed recommendations…2015 American Transplant Congress
Health Utilities in Pediatric Liver Transplant Recipients
Pediatrics, Northwestern U, Chicago.
Health Utilities (HU) are preference based measures of health states required for cost effectiveness studies. We measured HU and health related quality of life (HRQOL)…2015 American Transplant Congress
Controlled Hemodilution in Infant Liver Transplants: A Single Center Experience
Introduction: Hepatic artery thrombosis (HAT) remains a major comorbidity in pediatric liver transplants often resulting in graft loss and mortality. Controlled hemodilution decreases blood viscosity…2015 American Transplant Congress
Severe Sarcopenia and Increased Fat Stores in Pediatric Patients With Liver, Kidney and Intestine Failure
Transplant Division, Dept of Surgery, Indiana University School of Medicine, Indianapolis, IN.
Background: Recent research suggests that measures of frailty, such as nutrition status, may be important predictors of surgical and transplant outcomes. The objectively calculated degree…2015 American Transplant Congress
Age-Specific Graft Failure Rates in Pediatric Liver Transplant Recipients
Graft failure risk peaks during emerging adulthood (18-25 y) in kidney transplant recipients. The association between age and graft failure risk in liver transplant recipients…2015 American Transplant Congress
Ethnic Barriers in Pediatric Liver Transplant Recipients. A Retrospective Study
INTRODUCTION: Differences in access to OLTx continue to be present in minorities. Pediatric pts represent a particularly vulnerable population within minorities groups in need for…2015 American Transplant Congress
The Epidemiology of Surgical Site Infections Among Pediatric Liver Transplant Recipients
Background: Surgical site infections (SSI) are a significant cause of morbidity among adult liver transplant (LT) recipients. Data on SSI epidemiology and SSI-associated outcomes among…2015 American Transplant Congress
Are We Missing Cardiovascular Disease in Children Awaiting Liver Transplant?
Background: Cirrhotic cardiomyopathy, characterized by low systemic vascular resistance, is increasingly recognized as a complication of end stage liver disease. Yet optimal strategies to screen…2015 American Transplant Congress
Pediatric Liver Transplantation: An Outcome Analysis of a 30-Year Single Center Experience
Introduction: In this study we aim to assess factors influencing long-term patient and graft survival as well as surgical parameters and risk factors influencing organ…2015 American Transplant Congress
Increased Fibroblast Growth Factor 21 Levels in Biliary Atresia Patients
Renji Hospital, Shanghai, China.
Background: Fibroblast growth factor (FGF)-21, a hormone predominantly secreted by the liver, has recently been reported as a key circulating adipokine involving in metabolic disorders…
American Transplant Congress abstracts